Clinic
Methodist Healthcare System of San Antonio, LTD., LLP
Methodist Healthcare System of San Antonio, LTD., LLP was paid $4.99M by Medicaid between Jan 2020 and Dec 2024, across 55 billing codes. Its largest line is 99283, emergency room visit (moderate) — 57% of everything it billed.
33Billing provider infoMETHODIST HEALTHCARE SYSTEM OF SAN ANTONIO, LTD., LLP
JOURDANTON, TX 78026
JOURDANTON, TX 78026
33aNPI1376071530assigned 05/31/2017
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$4.99M
24GClaims51,505
24DCodes billed55
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#77 of 320
Median peer was paid$205K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,301 | $129K | |
| 2021 | 12,995 | $1.11M | |
| 2022 | 15,939 | $1.52M | |
| 2023 | 13,672 | $1.41M | |
| 2024incomplete | 7,598 | $826K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 57% | 11,608 | 11,318 | $2.82M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 5,578 | 5,243 | $1.55M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.1% | 1,559 | 1,528 | $356K |
| 80053 | Comprehensive metabolic panel | <1% | 4,794 | 4,341 | $38K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 25 | 25 | $34K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,973 | 2,775 | $34K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 177 | 169 | $25K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 198 | 186 | $24K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,476 | 2,405 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,155 | 1,896 | $18K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,518 | 1,348 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,151 | 2,017 | $11K |
43 more codes
| 85027 | <1% | 6,771 | $10K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 208 | $9K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 54 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 404 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 440 | $4K |
| 87070 | <1% | 327 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 476 | $2K |
| 83690 | <1% | 891 | $2K | |
| 81000 | <1% | 979 | $1K | |
| 84484 | <1% | 984 | $1K | |
| 76820 | <1% | 12 | $1K | |
| 87420 | <1% | 99 | $1K | |
| 83880 | <1% | 119 | $580.56 | |
| 83605 | <1% | 118 | $485.61 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $390.86 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 859 | $377.88 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 277 | $375.90 |
| 87040 | <1% | 107 | $375.56 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 445 | $369.55 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 15 | $281.11 |
| 85610 | <1% | 93 | $217.93 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 57 | $207.38 |
| 81003 | <1% | 215 | $168.28 | |
| 81001 | <1% | 159 | $143.42 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 74 | $84.56 |
| 83735 | <1% | 120 | $73.41 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 258 | $53.87 |
| 80061 | Lipid panel | <1% | 13 | $34.66 |
| 81025 | <1% | 32 | $29.84 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 29 | $21.73 |
| 87077 | <1% | 14 | $19.97 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 27 | $19.65 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 140 | $17.72 |
| 82550 | <1% | 14 | $16.08 | |
| 82248 | <1% | 87 | $15.21 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 27 | $10.44 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 14 | $10.35 |
| 85730 | <1% | 35 | $7.08 | |
| A9270 | Non-covered item or service | <1% | 1,119 | $6.37 |
| 84100 | <1% | 15 | $6.13 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 110 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 13 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVASQUEZ, JOE (CFO)